GL BIOCHEM
Building the Industrial Backbone of Peptide Science
Dr. Hongyan Xu, CEO & President
Peptide Synthesis
Peptide synthesis is the precision-driven production of short amino acid chains engineered to replicate or enhance biological functions. Central to pharmaceuticals, diagnostics, and biotech research, it enables targeted therapeutics, biomarker discovery, and advanced materials, bridging chemistry and biology to accelerate innovation in medicine, health optimization, and molecular science.
Solutions
GL BIOCHEM supports global life sciences programs through consistent, large-scale peptide production backed by controlled quality and reliable delivery timelines.
State of Industry
Transforming Peptide Synthesis: APAC Market Insights
Peptide synthesis infrastructure in the Asia Pacific (APAC) region is rapidly evolving, driven by advances in scientific capabilities, higher manufacturing standards, and market demands. This field has shifted from a niche role to an integral part of drug discovery and biotechnological advancements.
Deep Dive
Peptide Synthesis Shaping APAC Research Strategies
Life science organizations are placing growing emphasis on operational consistency, research scalability, and long-term innovation planning. Peptide-related workflows are increasingly viewed through a strategic lens rather than a purely technical one. Decisions surrounding these workflows influence collaboration models, investment priorities, and research reliability across academic and commercial environments. As research ecosystems mature, attention has shifted toward how disciplined approaches support quality, reproducibility, and efficiency at an organizational level. This broader outlook positions peptide-focused activities as part of a strategic research foundation that supports sustainable growth and competitive positioning throughout the APAC life sciences landscape.
Leadership Perspective
Kemin Industries
Comprehensive Biosecurity Containment and Anti-Viral Solutions to Tackling African Swine Fever to Ensure Better Food Security for Asia
Yee Wong, R&D Director | Animal Nutrition and Health, Asia Pacific
A. Severity of the ASF disease and economic impact
African swine fever (ASF) is a hemorrhagic disease affecting all ages of domestic and wild pigs, with very high mortality during infection with virulent strains, caused by a double-stranded DNA virus. Since the outbreak reported in China in August 2018, ASF has spread rapidly to 14 Asian countries including Indonesia, Vietnam, Cambodia, Mongolia and Laos. Infected products have also been found in South Korea, Japan, Taiwan and Australia. Approximately more than 120 million pigs from these countries have died due to ASF. A study done by Asian Development Bank estimated that the ASF would cost Asia between US$55 billion to US$130 billion. Major pork producers from Asia suffered severe losses and the burden is affecting many smallholder farmers, exacerbating poverty and food insecurity in the region. ASF has escalated the prices of pork and other food supplies, and negatively impacting human health, environment and trade.
Peptide Synthesis Info
Q1
What Do Peptide Synthesis Companies Do in Drug Discovery and Research?
Top Peptide Synthesis Companies specialize in designing and manufacturing peptides used in pharmaceuticals, biotechnology and academic research. It produces custom peptide sequences, modified peptides and peptide libraries that support applications such as drug development, diagnostics and vaccine research. Peptide synthesis companies enable scientists to study biological processes with precision, making them critical partners in modern life sciences innovation.
Q2
What Services Are Included in Peptide Synthesis Solutions?
Top Peptide Synthesis Companies offer a wide range of services including custom peptide synthesis, peptide modification and purification. These services often include analytical validation such as HPLC and mass spectrometry to confirm purity and structure. Peptide synthesis solutions also cover scale-up production, from small research quantities to large commercial batches, ensuring flexibility across early-stage research and industrial manufacturing.
Q3
Why Are Peptide Synthesis Companies Important in Pharmaceutical Development?
Top Peptide Synthesis Companies play a vital role in developing peptide-based therapeutics, which are increasingly used in treating chronic diseases and complex conditions. Their ability to produce high-purity peptides supports applications in drug discovery, gene editing and cell therapy. These companies help reduce development timelines by delivering reliable materials for testing and validation, improving efficiency across the pharmaceutical pipeline.
Q4
How Are Top Peptide Synthesis Companies Selected?
Top Peptide Synthesis Companies are evaluated based on synthesis quality, scalability and technical expertise. Decision-makers consider factors such as the ability to handle complex peptide structures, availability of advanced instrumentation and consistency in production output. Companies with strong R&D capabilities and global manufacturing infrastructure are often preferred, as they can support both research and commercial requirements at scale.
Q5
How Do Peptide Synthesis Companies Create Value for Biotech and Pharma Firms?
Top Peptide Synthesis Companies create value by accelerating research timelines and reducing production risks. Their integrated capabilities—covering synthesis, purification and characterization—allow clients to streamline workflows and focus on innovation. With the ability to produce thousands of peptides monthly and support diverse applications, peptide synthesis companies help organizations move efficiently from discovery to clinical development.
Q6
What Role Does Technology Play in Peptide Synthesis Companies?
Top Peptide Synthesis Companies rely on advanced technologies such as automated peptide synthesizers, high-performance liquid chromatography and mass spectrometry to ensure precision and consistency. These technologies enable the production of complex peptide structures with high purity and reproducibility. Continuous investment in instrumentation and process optimization allows peptide synthesis companies to meet growing demand and maintain competitive performance in a rapidly evolving market.
